India tightens rules on GLP-1 weight-loss drugs
India
India is tightening rules around popular GLP-1 weight-loss drugs after concerns about on-demand availability and potential health risks.
The government now wants to make sure these medications are only sold legally, whether in stores or online, to keep people safe.
What are the new rules?
Surrogate ads for these drugs are now banned to stop misleading claims.
Prescriptions are restricted to endocrinologists and internal medicine specialists, and for some indications to cardiologists only.
Regulators have already audited 49 places like online pharmacies and wellness clinics; those breaking the rules face penalties or even losing their licenses.
The health ministry says these steps are all about protecting people from risky misuse.